Healthcare is undergoing a fundamental reorientation — away from treating illness and toward optimizing performance before problems occur — and the fitness industry is positioned either to lead that shift or to be left behind by it. On LIFTS, the weekly fitness industry show hosted by Matthew Januszek, co-founder of Escape Fitness and partner in Escape Fitness USA, and Mohammed Iqbal, founder and CEO of SweatWorks, the two hosts sit down with Dr. Nestor Rodriguez to examine what this new era of performance medicine actually means for gym operators, wellness brands, and the professionals who work between fitness and healthcare.

The episode maps the forces accelerating the shift: GLP-1 medications changing consumer behavior and appetite for wellness services, wearable technology and diagnostics transforming what individuals can measure about their own health, and a growing consumer frustration with a reactive healthcare system that waits for illness rather than building resilience. Dr. Rodriguez explains why the next generation of health businesses will focus on optimizing energy, recovery, cognition, body composition, and long-term performance — and why fitness operators who position themselves within that ecosystem early may hold a significant competitive advantage.

What This Episode Covers

Performance medicine describes the shift from reactive sick care — treating conditions after they develop — to proactive optimization of human health across dimensions that include energy, recovery, cognition, body composition, and long-term performance. Rather than waiting until a patient presents with a problem, the performance medicine model uses diagnostics, biomarkers, wearable data, and personalized coaching to build and maintain peak function as a default state.

The concept sits at the intersection of longevity science, preventative healthcare, and the expanding definition of what fitness facilities and wellness operators can deliver. GLP-1 medications have accelerated the conversation by demonstrating consumer willingness to engage with pharmacological tools for body composition — and by opening questions about what comprehensive support looks like for people using those tools in combination with exercise and nutrition programming.

Dr. Nestor Rodriguez, the episode's guest, brings a clinical perspective to the discussion, explaining why many consumers have become frustrated with traditional healthcare systems and how the fitness and wellness industry is filling gaps that reactive medicine has historically left open. LIFTS — the podcast Matthew Januszek and Mo Iqbal produce together at liftspodcast.com — is the right venue for this conversation because it is explicitly an industry show: its audience is fitness operators, founders, investors, and professionals who need to understand where the market is heading, not just where it is today.

Key Moments from the Conversation

• Dr. Rodriguez explains the structural distinction between reactive sick care and proactive performance medicine, grounding the shift in specific consumer behaviors — including frustration with healthcare systems that only engage when problems become acute rather than helping people build and maintain resilience.
• GLP-1 medications are identified as an accelerant for the broader wellness movement: their adoption is changing consumer willingness to invest in body composition and health optimization tools, and creating new questions about what comprehensive support for GLP-1 users looks like when exercise, nutrition, and recovery are factored in.
• Wearables and diagnostics are transforming healthcare by putting real-time health data in the hands of consumers, and the episode examines how those data streams are changing expectations of what personalized health support should deliver — with implications for both healthcare providers and fitness operators.
• Personalization and diagnostics are described as increasingly essential rather than optional premium features, as consumers who have experienced data-driven health insights find it difficult to return to generic programming or one-size-fits-all wellness guidance.
• The role of coaching, behavior change, and biomarkers in the future of wellness is explored, with the conversation emphasizing that data alone does not produce outcomes — and that the translation of health data into meaningful behavior change is precisely where skilled fitness and wellness professionals provide value that technology cannot replicate.
• Longevity clinics and recovery services are positioned as early indicators of a broader market shift, with Dr. Rodriguez and the hosts examining how these specialized offerings signal where mainstream fitness facilities may evolve as the performance medicine model gains adoption.
• Operators who embrace the performance medicine framing early are described as having a potential competitive advantage, not because they can become medical providers but because they can position their facilities as partners in the proactive health ecosystem — a distinction that changes how clients think about membership value.

Why This Conversation Matters

For Matthew Januszek and Mo Iqbal, this episode represents exactly the kind of conversation LIFTS was built for: a forward-looking, industry-level analysis of a shift that is already underway but not yet fully legible to most operators. The performance medicine era is not a distant prediction — it is visible in the growth of longevity clinics, the mainstreaming of wearable diagnostics, the consumer behavior changes driven by GLP-1 adoption, and the expanding expectations consumers bring to their fitness and wellness providers. The hosts at liftspodcast.com surface these trends weekly so that the industry can navigate them with intention rather than react to them after the fact.

The specific question the episode title poses — whether the fitness industry is ready — is not rhetorical. It is a direct challenge to operators, founders, and investors to assess their own positioning against a standard that is being set by a new kind of health consumer: one who is already measuring their biomarkers, already using advanced therapeutics, and already expecting the facilities they choose to understand and support that level of engagement with their own health.

▶  Watch the full episode on YouTube

Related Episodes & Interviews

• The GLP-1 Game Changer →
• The SCREAM Framework →
• The Aescape Collapse with Frank Britt →